Skip to main content

Table 1 Composition of patient prostatectomy cohort used in current study

From: Automated quantitative multiplex immunofluorescence in situ imaging identifies phospho-S6 and phospho-PRAS40 as predictive protein biomarkers for prostate cancer lethality

 

# Samples

% Samples

Num DOD

% DOD

All

340

100

35

100

Gleason 2-6

124

36.47

2

5.71

Gleason 7

127

37.35

4

11.43

Gleason 8-10

89

26.18

29

82.86

Age at diagnosis - mean (SD)

61.9 (6.7)

Median followup years

11.92

  1. DOD: dead of disease. SD: standard deviation.